Health News

coffee helps hepatitis c treatment response
"Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, PhD, MPH, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies." Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable...
Two New Hepatitis C Drugs Butt Marketing Heads
Hepatitis C virus (HCV) is an infectious disease which is 100 times more infectious than HIV. People who inject drugs or engage in unprotected sex account for most people who are infected with hepatitis C.
Women Are One in Four of New HIV Infections in Ontario
Despite significant headway in HIV care and prevention, women account for 25 percent of new HIV cases in Ontario, Canada. Of these newly infected women, 93 percent acquired HIV by sexual contact. Additionally, 60 percent of these new female cases are immigrants.
Committed Couples Reality Gives HIV Awareness New Focus
Just as it is in committed heterosexual couples, gay couples in a serious relationship are much more likely to engage in unprotected sex. The idea of unprotected sex is a reality in all types of human sexual relationships.
HIV/AIDS: 30 years Later
It has been 30 years since the first case of acquired immunodeficiency syndrome (AIDS) was diagnosed in the United States. Currently, there are over a million estimated cases of HIV, the virus that causes AIDS, in the the United States. Twenty percent of those affected are unaware of their infection.
FDA Approves New HIV Treatment
The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naïve).
National HIV Vaccine Awareness Day
Thirty years since the first report of the disease we now know as AIDS, scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, continue advancing toward our goal of a vaccine to prevent HIV infection. I am optimistic that we will succeed.
FDA approves Victrelis for Hepatitis C
The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment. Victrelis is approved for use in combination with peginterferon alfa and ribavirin.
Organ Grinder's Sidekick and AIDS Solution
An organ grinder will tell you, "Those monkeys are great and will work for peanuts." Finally, the monkeys are the 'boss' with a promising new vaccine that is working for them.
HIV Vaccine in the Works
A new observation of the relationship between the HIV virus and certain antibodies is very exciting news from the land down under.